Summary
- Current Price
- As of today, CYCN price is $1.36, up +0.74% on
- Current Price All-Time High
- CYCN price is currently -99.70% below its historical high of $457.00 set on
- Market Cap
- CYCN current market cap is $5M, down -24.97% year-over-year
- PE Ratio
- CYCN PE ratio is unknown
- Revenue
- CYCN current annual revenue is $2.00M, up +100.00% year-over-year
- Next Earnings
- As of today, the next earnings release for CYCN has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Cyclerion Therapeutics, Inc. |
| Ticker | NASDAQ: CYCN |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | cyclerion.com |
| Employees | 1 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $1.36 | ||
| Price, 1D Change | +0.74% | |
| $5M | ||
| - | ||
| - | ||
| 0.59 | ||
| $2M | ||
| Revenue, 1Y Change | +100.00% | |
| -$1.21 | ||
| EPS, 1Y Change | +86.49% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:20 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.21 | ||
| EPS Estimate | N/A | -$1.34 |
| EPS Est. Change | N/A | -10.37% |
| $2.00M | ||
| Revenue Estimate | N/A | $1.10M |
| Revenue Est. Change | N/A | -45.00% |
| $1.36 | ||
| Price Target | - | $8.00 |
| Price Tgt. Change | - | +488.24% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | N/A | - | |
| -$1.34 | N/A | - | |
| -$1.20 | N/A | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | N/A | - | |
| $1.10M | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -49.82% | ||
| -91.42% | ||
| -24.97% | ||
| -85.00% | ||
| +100.00% | ||
| -49.26% | ||
| +86.49% | ||
| +95.40% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $1.36 | ||
| $2.27 | ||
| SMA 200 vs Price | +66.85% | |
| $1.43 | ||
| SMA 50 vs Price | +5.04% | |
| 0.59 | ||
| $0.13 | ||
| 51.73 | ||
| 92.89% | ||
| 100.34% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $2.00M | ||
| -$1.21 | ||
| $0.00 | ||
| 0.00% | ||
| -$3.63M | ||
| -181.40% | ||
| -$3.06M | ||
| -152.85% | ||
| -$3.63M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 5.83 | ||
| 5.83 | ||
| - | ||
| 3 | ||
| -35.43 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 1.81 | ||
| 0.54 | ||
| -0.17 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $8.85M | ||
| $3.23M | ||
| $9.58M | ||
| $4.23M | ||
| $725.00K | ||
| $725.00K | ||
| $0.00 | ||
| $0.00 | ||
| $390.00K |
Expenses
| Metric | Date | Value |
|---|---|---|
| $5.06M | ||
| $3.63M | ||
| - | ||
| $0.00 | ||
| $0.00 | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$4.33M | ||
| $0.00 | ||
| $0.00 | ||
| $0.00 | ||
| -$4.33M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Truist Securities | ||
| Cantor Fitzgerald |
Analyst sentiment
Institutional ownership
Screeners with CYCN
FAQ
What is the ticker symbol for Cyclerion Therapeutics, Inc.?
The ticker symbol for Cyclerion Therapeutics, Inc. is NASDAQ:CYCN
Does Cyclerion Therapeutics, Inc. pay dividends?
No, Cyclerion Therapeutics, Inc. does not pay dividends
What sector is Cyclerion Therapeutics, Inc. in?
Cyclerion Therapeutics, Inc. is in the Healthcare sector
What industry is Cyclerion Therapeutics, Inc. in?
Cyclerion Therapeutics, Inc. is in the Biotechnology industry
What country is Cyclerion Therapeutics, Inc. based in?
Cyclerion Therapeutics, Inc. is headquartered in United States
When did Cyclerion Therapeutics, Inc. go public?
Cyclerion Therapeutics, Inc. initial public offering (IPO) was on March 18, 2019
Is Cyclerion Therapeutics, Inc. in the S&P 500?
No, Cyclerion Therapeutics, Inc. is not included in the S&P 500 index
Is Cyclerion Therapeutics, Inc. in the NASDAQ 100?
No, Cyclerion Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Cyclerion Therapeutics, Inc. in the Dow Jones?
No, Cyclerion Therapeutics, Inc. is not included in the Dow Jones index
When was Cyclerion Therapeutics, Inc. last earnings report?
Cyclerion Therapeutics, Inc.'s most recent earnings report was on November 14, 2025
When does Cyclerion Therapeutics, Inc. report earnings?
The date for Cyclerion Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- CYCN Official Website www.cyclerion.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1755237/000119312525277749/0001193125-25-277749-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1755237/000095017025032037/0000950170-25-032037-index.htm
- CYCN Profile on Yahoo Finance finance.yahoo.com/quote/CYCN
- CYCN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cycn